14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $64.82 $75.66 Wednesday, 24th Apr 2024 CYTK stock ended at $66.82. This is 1.91% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.69% from a day low at $65.68 to a day high of $67.45.
90 days $61.33 $84.05
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Jun 07, 2021 $20.27 $23.05 $20.23 $22.33 852 143
Jun 04, 2021 $21.22 $21.33 $20.32 $20.42 647 091
Jun 03, 2021 $20.78 $21.11 $20.35 $21.04 410 358
Jun 02, 2021 $21.75 $22.02 $20.53 $20.94 926 848
Jun 01, 2021 $21.94 $22.14 $21.36 $21.70 698 939
May 28, 2021 $22.35 $22.80 $21.70 $21.83 679 706
May 27, 2021 $22.43 $22.56 $21.96 $22.32 645 128
May 26, 2021 $22.64 $23.43 $22.04 $22.26 399 683
May 25, 2021 $22.83 $22.84 $21.98 $22.33 558 574
May 24, 2021 $23.05 $23.62 $22.70 $22.75 423 628
May 21, 2021 $24.05 $24.39 $23.02 $23.05 1 782 238
May 20, 2021 $23.81 $24.30 $23.43 $23.84 1 421 485
May 19, 2021 $23.58 $23.90 $23.15 $23.76 1 361 800
May 18, 2021 $25.89 $26.07 $23.95 $23.96 650 161
May 17, 2021 $25.70 $26.18 $25.41 $25.57 390 688
May 14, 2021 $25.37 $26.15 $25.13 $25.93 489 592
May 13, 2021 $24.42 $25.32 $24.21 $25.23 613 118
May 12, 2021 $23.50 $25.03 $23.50 $24.32 773 955
May 11, 2021 $23.06 $23.86 $22.78 $23.77 764 627
May 10, 2021 $24.20 $24.26 $23.02 $23.38 627 055
May 07, 2021 $23.01 $24.65 $22.86 $24.23 1 158 649
May 06, 2021 $23.26 $23.62 $22.60 $23.37 786 866
May 05, 2021 $24.12 $24.50 $23.31 $23.58 812 926
May 04, 2021 $25.61 $26.01 $24.00 $24.25 1 553 557
May 03, 2021 $25.68 $26.44 $25.32 $25.92 675 312
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT